首页> 外文期刊>Technology review >FDA Takes On Personalized Medicine
【24h】

FDA Takes On Personalized Medicine

机译:FDA接受个性化医学

获取原文
获取原文并翻译 | 示例
           

摘要

Personalized medicine does not fit easily into established government procedures for approving drugs. After all, clinical trials are designed to test a drug on a large and diverse group of patients, and the whole point of personalized therapeutics is to target the specific genetic populations that will benefit most. The U.S. Food and Drug Administration is now trying to figure out how to judge the usefulness of a drug designed for particular genetic groups while also considering its safety for others who may receive it for off-label purposes.
机译:个性化药物不容易适应政府批准药物的既定程序。毕竟,临床试验旨在针对大量不同的患者群测试药物,个性化治疗的重点是针对将受益最大的特定基因人群。美国食品药品监督管理局现在正试图弄清楚如何判断为特定遗传人群设计的药物的有效性,同时还要考虑其对可能出于标签外用途接受其他药物的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号